The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 350.00
Bid: 350.00
Ask: 355.00
Change: 10.00 (2.94%)
Spread: 5.00 (1.429%)
Open: 335.00
High: 350.00
Low: 335.00
Prev. Close: 340.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

6 Jul 2017 07:00

RNS Number : 2365K
Microgen PLC
06 July 2017
 

6 July 2017

 

MICROGEN plc ('Microgen' or 'Group')

 

TRADING UPDATE AND NOTICE OF RESULTS

 

 

Ahead of announcing Interim Results for the six months ended 30 June 2017 on 24 July 2017, Microgen (MCGN.L), a leading provider of business critical software and services, today issues the following update on trading for the financial year to date.

The Group has made excellent progress in the first half of 2017 resulting in a financial performance ahead of the Board's original expectations for the period whilst maintaining margins consistent with the prior year. The Group's two businesses are successfully executing their declared strategy with Aptitude Software delivering strong organic growth and Microgen Financial Systems successfully continuing on its transition towards a business focused on the Trust & Fund Administration ('T&FA') market.

A key highlight for the Group is the continued new business wins that have driven growth in Aptitude Software's recurring revenue base. Since 30 June 2016, the recurring revenue in Aptitude Software has increased 42% to £15.0 million as at 30 June 2017 (H1, 2016: £10.6 million and 31 December 2016: £12.6 million). There has also been exceptional growth in demand for Aptitude Software's implementation services in the first half of the year as a number of clients progress towards going live with the Aptitude Revenue Recognition Engine ('ARRE'). Upon completion of the half year the Board has reviewed the on-going demand for Aptitude Software's implementation services and, whilst clients' requirements continue to evolve, the Board is now confident that the exceptional level of demand experienced in the first six months of the year will continue throughout 2017, leading to a financial performance for the Group significantly ahead of the Board's expectations for the year. 

Opportunities for Aptitude's existing software and its new products provide the business with confidence for future years. Partners are becoming an increasingly important channel for new business, and as they provide a growing proportion of resources for new implementations, and as a number of the larger ARRE projects are completed, the exceptional level of demand for services experienced in 2017 is expected to moderate in 2018.

Microgen Financial Systems has maintained its focus on the T&FA market within the wealth management sector. The acquisition of Primacy Corporation in February 2017, a competitor in the T&FA market, represented the fifth acquisition since December 2014 and further strengthens the position of the business in this market. As a result of this focus T&FA revenues now represent approximately 60% of Microgen Financial Systems' H1 2017 revenue (H1, 2016: 51%), compared to 33% at the beginning of this transition in 2014.

 

Contacts

Ivan Martin, Chairman 020-7496-8100

Philip Wood, Chief Financial Officer

 

James Melville-Ross / Darius Alexander 020-3727-1000

FTI Consulting

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUUGMUPMGAA
Date   Source Headline
1st Mar 20221:00 pmRNSTotal Voting Rights
1st Feb 202211:05 amRNSTotal Voting Rights
20th Jan 20227:00 amRNSTrading Update and Notice of Results
1st Dec 20217:00 amRNSTotal Voting Rights
8th Nov 20215:05 pmRNSGrant of awards under Performance Share Plan
1st Nov 20214:50 pmRNSTotal Voting Rights
25th Oct 20217:00 amRNSBlock Listing Application
11th Oct 20217:00 amRNSAcquisition of MPP Global Solutions Limited
1st Oct 20217:00 amRNSNon-Executive Directorate and Committee Changes
28th Sep 202111:24 amRNSBlock listing Interim Review
17th Sep 20217:00 amRNSChange of Auditor
28th Jul 20217:00 amRNSInterim Results
16th Jul 20217:00 amRNSNotice of Results
6th Jul 202110:39 amRNSHolding(s) in Company
1st Jul 20217:00 amRNSTotal Voting Rights
15th Jun 20219:57 amRNSDirector Declaration
27th May 20218:20 amRNSDirector Declaration
6th May 20213:36 pmRNSDirector/PDMR Shareholding and Total Voting Rights
5th May 20213:27 pmRNSHolding(s) in Company
4th May 20218:55 amRNSTotal Voting Rights
29th Apr 20217:00 amRNSAppointment of Joint Broker
27th Apr 202111:28 amRNSResult of AGM
27th Apr 20217:00 amRNSAGM Statement
9th Apr 202111:14 amRNSHolding(s) in Company
29th Mar 20212:06 pmRNSBlock listing Interim Review
23rd Mar 202111:13 amRNSDirector/PDMR Shareholding
11th Mar 20214:44 pmRNSBlock Listing Application
2nd Mar 20217:00 amRNSNotice of Results
1st Mar 202112:36 pmRNSTotal Voting Rights
19th Jan 20217:00 amRNSTrading Update
6th Jan 20214:23 pmRNSHolding(s) in Company
4th Jan 20217:00 amRNSTotal Voting Rights
18th Dec 20209:13 amRNSHolding(s) in Company
1st Dec 202010:09 amRNSTotal Voting Rights
23rd Nov 20205:37 pmRNSHolding(s) in Company
28th Oct 20201:58 pmRNSDirector/PDMR Shareholding
29th Sep 20204:41 pmRNSSecond Price Monitoring Extn
29th Sep 20204:35 pmRNSPrice Monitoring Extension
28th Sep 202010:48 amRNSBlock listing Interim Review
9th Sep 20204:24 pmRNSGrant of awards under Performance Share Plan
2nd Sep 20201:38 pmRNSDirector Declaration
11th Aug 202012:19 pmRNSDirector/PDMR Shareholding
29th Jul 20207:00 amRNSInterim Results
6th Jul 20207:23 amRNSHolding(s) in Company
6th Jul 20207:21 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSTrading Update and Notice of Results
11th Jun 20204:41 pmRNSSecond Price Monitoring Extn
11th Jun 20204:36 pmRNSPrice Monitoring Extension
10th Jun 20204:35 pmRNSPrice Monitoring Extension
2nd Jun 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.